Santamarta D, Blázquez J A, Maillo A, Muñoz A, Caballero M, Morales F
Servicio de Neurocirugía y Servicio de Otorrinolaringología y Patología Cervicofacial. Hospital Universitario de Salamanca Virgen de la Vega Salamanca, España.
Neurocirugia (Astur). 2003 Apr;14(2):117-26. doi: 10.1016/s1130-1473(03)70548-x.
Hydrocephalus, cerebrospinal fluid (CSF) leak, pseudomeningocele and CSF infection are potential complications related to surgical treatment of posterior fossa tumors. The objectives of this study were to review the incidence of such complications and to identify contributing factors related to them.
This study is based on a retrospective review of the medical records of 71 consecutive patients who underwent posterior fossa surgery for a tumor between the period January 1997 and December 2001. Postoperative hydrocephalus was defined as enlargement of the ventricles and the subsequent clinical worsening requiring surgical treatment. Criteria for CSF leakage were:observed leak of CSF through the wound, rhinorrhea or otorrhea. Pseudomeningocele was determined when there was a large epidural CSF collection diagnosed in the postoperative period or by magnetic resonance imaging performed at least three months after posterior fossa surgery. Finally, CSF infection was defined on clinical ground and positive biochemical examination, but not necessarily positive cultures.
The series included 84 operations for resection of posterior fossa tumors on 71 patients. There were CSF related complications in 31% (26/84)with the following detailed incidence: 9.5% (8/84) postoperative hydrocephalus; 14.3% (12/84) CSF leak, 7.1% (6/84) pseudomeningocele; 8.3% (7/84) CSF infection. The mortality rate is 5.9% (5/84). The tumor size was the only statistically significant factor associated with the occurrence of CSF related complications (mean 39.43 mm, SD 18.51 mm vs.29.80 mm, SD 14.12 mm, p=0.015). In the subgroup of patients, in which hydrocephalus was managed preoperatively, the election of an external ventricular drain vs.other strategies (subcutaneous reservoir, definite shunt or endoscopic third ventriculostomy) was associated with a higher occurrence of CSF related complications (p=0.006). The mortality rate was associated with age (mean 63.60 years, SD 5.86 years vs.49.18 years, SD 16.39 years; p=0.002). The occurrence of CSF related complications also influenced mortality (p=0.030), particularly postoperative hydrocephalus (p< 0.001). Inpatient hospital stay was longer in the subgroup of patients who developed CSF related complications (p=0.002).
Tumor size was the only factor associated with the development of CSF related complications after surgery for posterior fossa tumors. In the subgroup of patients in which hydrocephalus was surgically treated preoperatively, the election of an external ventricular drain compared to other surgical modalities was associated with a higher rate of CSF related complications. The development of such complications, particularly hydrocephalus, was related with mortality.
脑积水、脑脊液漏、假性脑脊膜膨出和脑脊液感染是后颅窝肿瘤手术治疗的潜在并发症。本研究的目的是回顾此类并发症的发生率,并确定与之相关的影响因素。
本研究基于对1997年1月至2001年12月期间连续71例因肿瘤接受后颅窝手术患者的病历进行回顾性分析。术后脑积水定义为脑室扩大且随后临床症状恶化需要手术治疗。脑脊液漏的标准为:观察到脑脊液通过伤口漏出、鼻漏或耳漏。当术后或后颅窝手术后至少三个月进行的磁共振成像检查发现硬膜外有大量脑脊液聚集时,确定为假性脑脊膜膨出。最后,脑脊液感染根据临床症状和生化检查阳性来定义,但不一定是培养阳性。
该系列包括对71例患者进行的84次后颅窝肿瘤切除术。脑脊液相关并发症发生率为31%(26/84),具体发生率如下:术后脑积水9.5%(8/84);脑脊液漏14.3%(12/84);假性脑脊膜膨出7.1%(6/84);脑脊液感染8.3%(7/84)。死亡率为5.9%(5/84)。肿瘤大小是与脑脊液相关并发症发生相关的唯一具有统计学意义的因素(平均39.43mm,标准差18.51mm vs. 29.80mm,标准差14.12mm,p = 0.015)。在术前接受脑积水治疗的患者亚组中,选择外部脑室引流与其他策略(皮下储液器、确定性分流或内镜下第三脑室造瘘术)相比,脑脊液相关并发症的发生率更高(p = 0.006)。死亡率与年龄相关(平均63.60岁,标准差5.86岁 vs. 49.18岁,标准差16.39岁;p = 0.002)。脑脊液相关并发症的发生也影响死亡率(p = 0.030),尤其是术后脑积水(p < 0.001)。发生脑脊液相关并发症的患者亚组住院时间更长(p = 0.002)。
肿瘤大小是后颅窝肿瘤手术后发生脑脊液相关并发症的唯一相关因素。在术前接受脑积水手术治疗的患者亚组中,与其他手术方式相比,选择外部脑室引流与更高的脑脊液相关并发症发生率相关。此类并发症的发生,尤其是脑积水,与死亡率相关。